Nipro Corporation (TYO:8086)
1,257.50
-31.00 (-2.41%)
May 22, 2025, 3:30 PM JST
Nipro Revenue
In the fiscal year ending March 31, 2025, Nipro had annual revenue of 644.59B JPY with 9.85% growth. Nipro had revenue of 165.30B in the quarter ending March 31, 2025, with 11.96% growth.
Revenue
644.59B
Revenue Growth
+9.85%
P/S Ratio
0.32
Revenue / Employee
16.91M
Employees
38,117
Market Cap
205.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 644.59B | 57.80B | 9.85% |
Mar 31, 2024 | 586.79B | 41.59B | 7.63% |
Mar 31, 2023 | 545.20B | 50.41B | 10.19% |
Mar 31, 2022 | 494.79B | 39.23B | 8.61% |
Mar 31, 2021 | 455.56B | 13.04B | 2.95% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |